Pr Christophe Massard

Specialty

Oncologist, bladder expert, prostate expert

Title

Head of the Early Trials Department (DITEP)

Hospital

Gustave Roussy (Villejuif)

Latest articles

• First-in-human phase 1 study of KHK2455 monotherapy and in combination with mogamulizumab in patients with advanced solid tumors. (Jul 1, 2025)
• Induction of tertiary lymphoid structures in tumor microenvironment to improve anti-tumoral immune checkpoint blockade efficacy. (Jun 9, 2025)
• Baseline CT-derived tumor burden and liquid biopsy as biomarkers to predict survival in patients with metastatic solid cancer. (Jun 7, 2025)
• Age Does not Affect the Efficacy of Antibody Drug Conjugates, But is Associated with High-Grade Adverse Events in Patients with Cancer Enrolled in Early Phase Clinical Trials. (Jun 1, 2025)
• Innovative, early-phase clinical trials of drug-radiotherapy combinations. (Apr 1, 2025)